Deferiprone

FDA Approved: * February 8, 2019
Pharm Company: * TARO PHARM INDS LTD
Category: Iron Chelator

Deferiprone, sold under the brand name Ferriprox among others, is a medication that chelates iron and is used to treat iron overload in thalassaemia major.[3] It was first approved and indicated for use in treating thalassaemia major in 1994[4] and had been licensed for use in the European Union and in Asia for many years while awaiting approval in Canada and in the United States.[3] On October 14, 2011, it was approved for use in the US under ... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Deferiprone 500 mg Oral Tablet, Coated
NDC: 0054-0576
Labeler:
Hikma Pharmaceuticals USA Inc.
Deferiprone 1000 mg Oral Tablet, Coated
NDC: 0054-0711
Labeler:
Hikma Pharmaceuticals USA Inc.
Deferiprone 500 mg Oral Tablet
NDC: 51672-4196
Labeler:
Taro Pharmaceuticals U.S.a., Inc.

Related Brands

Drugs with the same active ingredients